arrow
G

Geny Piro

comprehensive cancer center, irccs fondazione policlinico universitario agostino gemelli, rome, italy
H指数:30
被引数:2,551

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance

PI3K/mTORC2-RICTOR轴在早期鳞状非小细胞肺癌中的研究:基因组学、分子表达及其临床相关性

2025-11-070
OA
Local ablation disrupts immune evasion in pancreatic cancer
2025-01-010
OA
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance
2024-12-041
OAAI
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer

MAPK信号传导的差异活性定义了胰腺癌中的成纤维细胞亚型

2024-12-030
OAAI
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer
2023-11-236
OAAI
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients

免疫检查点阻断疗法可减轻非进展期非小细胞肺癌患者的全身炎症并影响表达细胞FLIP的单核细胞髓源性抑制细胞

2023-09-145
OA
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer

CXCR1/2双重抑制剂ladarixin可减轻肿瘤负担并促进胰腺癌的免疫治疗反应

2022-11-1614
OA
A NOVEL IL12-BASED IMMUNOCYTOKINE TARGETING FIBROBLAST ACTIVATION PROTEIN (FAP) FOR THE TREATMENT OF CANCER
2022-11-071
OA
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer

解开有丝分裂纺锤体: 肺癌中的极光激酶抑制剂的重点

2022-10-279
OAAI
Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody

基于新型抗人FAP单克隆抗体的IL-12融合蛋白的制备和体内验证

2022-09-1415
OAAI
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures

针对晚期非小细胞肺癌的KRAS复兴: 旧失败后的新机遇

2021-12-232
OAAI